Editorial: adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease. Issue 1 (2nd December 2016)

• Record Type: Journal Article
• Authors: Christensen, B.; Sparrow, M. P.
• Is Part Of: Alimentary pharmacology & therapeutics. Volume 45:Issue 1(2017)
• Page Start: 178
• Page End: 179
• Publication Date: 2016-12-02
• Subjects: Digestive organs -- Diseases -- Treatment -- Periodicals; Digestive organs -- Effect of drugs on -- Periodicals; Gastrointestinal system -- Diseases -- Treatment -- Periodicals; Gastrointestinal system -- Effect of drugs on -- Periodicals; 615.73
• DOI: 10.1111/apt.13842
• Languages: English
• ISSNs: 0269-2813

Abstract

Abstract : Linked Content This article is linked to Cosnes et al paper. To view this article visithttps://doi.org/10.1111/apt.13808 .